ALENDRONATE SODIUM
NDC 68788-7130, Alendronate sodium, tablet, from Preferred Pharmaceuticals Inc..
- Product NDC
- 68788-7130
- Status
- Listed
- Labeler
- Preferred Pharmaceuticals Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA076768
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALENDRONATE SODIUM70 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68788-7130-4 | 68788713004 | 4 TABLET in 1 BLISTER PACK (68788-7130-4) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/83e3ba94-d882-4b5c-87cb-af1eb0997efc
Use it
Look up 68788-7130 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68788-7130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.